We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$677M
AUM Growth
-$50M
(-6.9%)
Cap. Flow
-$67.1M
Cap. Flow
% of AUM
-9.92%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,031
New
439
Increased
126
Reduced
146
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.2M |
| 2 |
Kimberly-Clark
KMB
|
+$8.57M |
| 3 |
SBA Communications
SBAC
|
+$7.81M |
| 4 |
PG&E
PCG
|
+$5.73M |
| 5 |
Advance Auto Parts
AAP
|
+$5.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$15.6M |
| 2 |
Pfizer
PFE
|
+$14.6M |
| 3 |
Dominion Energy
D
|
+$13.4M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.9M |
| 5 |
Cadence Design Systems
CDNS
|
+$9.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.25% |
| 2 | Technology | 16.12% |
| 3 | Industrials | 11.55% |
| 4 | Financials | 11.01% |
| 5 | Healthcare | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
226
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $900K | 0.13% |
14,220
+5,810
| +69% | +$362K |
|
227
First Horizon
FHN
$12.1B
| $897K | 0.13% |
+79,620
| New | +$1.07M |
|
228
Bumble
BMBL
$373M
| $881K | 0.13% |
+52,491
| New | +$907K |
|
|
229
Broadcom
AVGO
$2.04T
| $879K | 0.13% |
10,130
-219,410
| -96% | -$15.6M |
|
230
Trade Desk
TTD
$6.49B
| $868K | 0.13% |
+11,247
| New | +$761K |
|
231
Alphabet (Google) Class A
GOOGL
$4.33T
| $863K | 0.13% |
+7,211
| New | +$830K |
|
232
Sysco
SYY
$40.3B
| $851K | 0.13% |
+11,475
| New | +$849K |
|
233
Doximity
DOCS
$4.88B
| $849K | 0.13% |
+24,962
| New | +$831K |
|
234
Starbucks
SBUX
$120B
| $833K | 0.12% |
+8,405
| New | +$872K |
|
235
Liberty Broadband Class C
LBRDK
$5.15B
| $833K | 0.12% |
10,393
+6,608
| +175% | +$511K |
|
|
XYZ
236
Block Inc
XYZ
$47.5B
| $823K | 0.12% |
+12,362
| New | +$772K |
|
237
KB Home
KBH
$3.59B
| $821K | 0.12% |
+15,877
| New | +$716K |
|
238
Deere & Co
DE
$168B
| $818K | 0.12% |
2,019
+896
| +80% | +$343K |
|
239
Valmont Industries
VMI
$9.53B
| $814K | 0.12% |
+2,797
| New | +$808K |
|
|
CNR
240
Core Natural Resources Inc
CNR
$4.45B
| $813K | 0.12% |
11,994
+3,151
| +36% | +$192K |
|
241
Paycom
PAYC
$9.69B
| $795K | 0.12% |
2,474
-4,190
| -63% | -$1.24M |
|
242
Roblox
RBLX
$27B
| $792K | 0.12% |
19,648
-20,270
| -51% | -$814K |
|
243
Cinemark Holdings
CNK
$4.32B
| $784K | 0.12% |
47,522
-20,234
| -30% | -$336K |
|
244
First Citizens BancShares
FCNCA
$25.3B
| $774K | 0.11% |
+603
| New | +$698K |
|
245
SAP
SAP
$238B
| $764K | 0.11% |
+5,582
| New | +$738K |
|
246
Rollins
ROL
$18.2B
| $762K | 0.11% |
17,787
-6,193
| -26% | -$252K |
|
247
Jacobs Solutions
J
$17B
| $760K | 0.11% |
7,727
-16,017
| -67% | -$1.53M |
|
248
Southern Copper
SCCO
$166B
| $760K | 0.11% |
11,421
+247
| +2% | +$16.9K |
|
|
ERF
249
DELISTED
Enerplus Corporation
ERF
| $758K | 0.11% |
52,309
-31,694
| -38% | -$462K |
|
250
Kraft Heinz
KHC
$30B
| $754K | 0.11% |
+21,241
| New | +$817K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
MA
TCM
HBWM
Aigen Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Aigen Investment Management held 1,031 positions worth $677M, down 6.9% from $727M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Aigen Investment Management withdrew a net $67.1M in Q2 2023, closing 320 positions and reducing 146 holdings. Its most notable exit was Pfizer, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aigen Investment Management opened a new position in Apple worth $11.4M.
- Aigen Investment Management's largest Q2 2023 buy was Apple: 58,654 shares worth $11.4M.
- Aigen Investment Management added most to Advance Auto Parts in Q2 2023, an estimated $5.62M increase.
- Aigen Investment Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $15.6M.
- Aigen Investment Management fully exited Pfizer in Q2 2023, selling an estimated $14.6M.
- Aigen Investment Management's ten largest holdings make up 11% of its $677M portfolio in Q2 2023.
- Aigen Investment Management opened 439 new positions and closed 320 in Q2 2023.
- Aigen Investment Management's portfolio value fell 6.9% quarter-over-quarter to $677M.
Based on Aigen Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.